MGI Offering Could Gross $128M Following FDA Approval Of Aloxi July 29, 2003 By Aaron Lorenzo Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today)Read More
